Efficacy of Lutein, Zeaxanthine and Trypan Blue to Stain the Anterior Lens Capsule
NCT ID: NCT01621789
Last Updated: 2016-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
25 participants
INTERVENTIONAL
2012-06-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anterior Chamber Illumination in Cataract Surgery for Eyes With Poor Red Reflex
NCT04220138
Oct Angiography Changes After Local Anesthesia in Cataract Surgery
NCT07298746
Cataract Surgery Technique and Ocular Clarity
NCT05489198
Anaesthesia for Ophthalmic Surgery: How "Retro" is the Peribulbar Block?
NCT01258959
Quantification of Posterior Capsule Opacification in Pediatric Cataract
NCT02968290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dye of lutein, zeaxanthin, trypan blue
during the surgery will be evaluated if the dye is suitable for dyeing anterior lens capsule
dye of lutein, zeaxanthin, trypan blue
dye composed of lutein, zeaxanthin, trypan blue
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dye of lutein, zeaxanthin, trypan blue
dye composed of lutein, zeaxanthin, trypan blue
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of cataract (nuclear, entumecente, total)
* Absence of red reflex
* Indication of cataract surgery
Exclusion Criteria
* Any history of eye disease
* Glaucoma
* Eye infection affecting any structure prior ocular
* Any previous ocular surgery
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rubens Belfort Jr.
Full Professor of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rubens Belfort Jr, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Fderal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Ophthalmology - UNIFESP/Hospital São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vianna LM, Cohen MJ, Muccioli C, Lima A, Sousa-Martins D, Maia M, Belfort R Jr. Efficacy of a lutein-based dye (Phacodyne) for visualizing anterior capsulorhexis during cataract surgery by phacoemulsification. Arq Bras Oftalmol. 2014 May-Jun;77(3):173-7. doi: 10.5935/0004-2749.20140044.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEP 2146/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.